Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Vivek Ramaswamy-Backed Strive, Asset Entities Get Shareholder Approval To Merge, Launch $1.5 Billion Public Bitcoin Treasury Company

Asset Entities Inc. (NASDAQ:ASST) shareholders approved a reverse merger with Vivek Ramaswamy-backed Strive Enterprises, creating what executives call a leading public Bitcoin (CRYPTO: BTC) treasury company with potential $1.5 billion in funding.

Benzinga

Palantir CEO Alex Karp Denies Spying On Americans, Says Firm Has 'Worst' Tech To Abuse Civil Liberties

On Tuesday, Palantir Technologies Inc. (NASDAQ:PLTR) CEO Alex Karp strongly pushed back against claims the company spies on U.S. citizens, defending its platforms as among the hardest technologies in the world to abuse as its stock price and revenue surge.

Benzinga

Is Paychex Stock Underperforming the Nasdaq?

Paychex has notably underperformed the Nasdaq Composite over the past 52 weeks, and analysts remain cautious about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Asset Entities Stock Trends, Soars 52%, On Strive Merger Approval: Another Bitcoin Treasury Company In The Making

Asset Entities Inc. (NASDAQ:ASST) is trending on Wednesday.

Benzinga

Mark Zuckerberg's Costly AI Talent Hunt Sparks Backlash As Million-Dollar Recruits Quit, Secretive 'TBD Lab' Breeds Tension At Meta: Report

Meta Platforms Inc. (NASDAQ:META) faces mounting internal tensions after CEO Mark Zuckerberg‘s artificial intelligence recruitment drive sparked employee departures and compensation disputes.

Benzinga

Elon Musk Shares Updates On Robots, Starlink-Enabled Smartphones, AI Push In Latest Interview, Says Optimus Could Be 'Biggest Product Ever'

Tesla Inc. (NASDAQ:TSLA) CEO Elon Musk has shared updates on autonomous driving, Optimus humanoid robots and artificial intelligence pursuits during a recent event.

Benzinga

Jim Cramer Says Microsoft Paying Amazon's Anthropic For AI Is 'Big': Redmond Shifting Strategy?

On Tuesday, Jim Cramer said Microsoft Corporation's (NASDAQ:MSFT) decision to pay Amazon.com, Inc. (NASDAQ:AMZN) -backed Anthropic for artificial intelligence features in Office apps marks a major change in strategy after years of relying heavily on OpenAI.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Thinnest iPhone Ever, Longest Battery: Enough To Spark A Supercycle For Apple? — Daniel Newman Has Doubts

On Tuesday, Apple Inc.'s (NASDAQ:AAPL) "Awe Dropping" event drew a mix of enthusiasm and skepticism from analysts, who praised the company's camera upgrades and thinner designs but questioned whether the iPhone 17 lineup offers enough innovation to ignite investor excitement.

Benzinga

OpenAI CEO Sam Altman Calls iPhone Air 'First Upgrade I Really Wanted In Awhile' Following Apple's Latest Launch

OpenAI CEO Sam Altman praised Apple Inc. (NASDAQ:AAPL) for its iPhone 17 launch on Tuesday, marking the first Apple upgrade he’s genuinely wanted in years. His endorsement comes as Apple shares fell 1.83% following the “Awe Dropping” event unveiling the company’s latest device lineup.

Benzinga

Is Qualcomm Tesla’s Next Rival in Autonomous Driving?

Tesla may still dominate the autonomous headlines, but Qualcomm’s partnership with BMW make it an interesting alternative for investors to consider.

MarketBeat

Eric Trump will no longer serve as board director of cryptocurrency firm

IN FULL

The Independent UK

What Happened With Bitcoin Treasury Kindly MD Stock Today?

Kindly MD, Inc. (NASDAQ:NAKA) shares ran on Tuesday on likely sympathy with fellow crypto-treasury company QMMM Holdings Ltd (NASDAQ:QMMM), which soared more than 1700%.

Benzinga

Eric Trump booted from cryptocurrency board after company talks with stock regulators

Fintech firm Alt5 Sigma announced in August that President Donald Trump’s son Eric was joining its board of directors

The Independent UK

Synopsys Stock Drops After Disappointing Q3 Earnings

Synopsys, Inc. (NASDAQ:SNPS) released its third-quarter results after Tuesday's closing bell. Here's a look at the key figures from the quarter.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Stocks Settle Higher on Hopes of Accelerated Fed Rate Cuts

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.43%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.33%. September E-mini S&P futures (ESU25 ) rose +0.28%, and September E-mini Nasdaq futures...

Benzinga

Quantum Stock Tracker: Nvidia Backs Quantinuum; D-Wave, IonQ Announce New Execs

Quantum stocks climbed Tuesday as anticipated interest rate cuts and a broader bullish move in tech stocks provided a supportive backdrop for innovation sectors like quantum computing.

Benzinga

Oracle Turns 50 Soon - And It's Burning Billions To Stay Relevant

For a company nearing its 50th birthday, Oracle Corp (NYSE:ORCL) is acting more like a cash-burning startup than a tech elder statesman. Once the software king of the '80s and '90s, Oracle stumbled through the cloud transition but is now betting big on AI infrastructure.

Benzinga

Regeneron's Libtayo Combo Achieves Nearly Double Survival Rate In Advanced Lung Cancer Compared To Chemotherapy

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on Tuesday announced five-year follow-up results on overall survival (OS) from the Phase 3 EMPOWER-Lung 3 trial of Libtayo (cemiplimab) plus platinum-based chemotherapy versus chemotherapy alone as a first-line treatment for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) with no EGFR, ALK,…

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis

Amgen Inc. (NASDAQ:AMGN) and Kyowa Kirin released preliminary topline results from the ASCEND study evaluating rocatinlimab in adults and adolescents with moderate to severe atopic dermatitis (AD) on Tuesday.

Benzinga

Apple Launches iPhone 17 Series Starting At $799: Tim Cook Calls It 'Unlike Anything We've Ever Created'

On Tuesday at the "Awe Dropping" event, Apple Inc. (NASDAQ:AAPL) unveiled its iPhone 17 lineup. As of this writing, Apple shares were down 1.36%, per Benzinga Pro data.

Benzinga

Nebius Shares Are Trading Higher Tuesday: What's Going On?

Nebius Group N.V. (NASDAQ:NBIS) shares are trading higher Tuesday after the company announced it secured up to a $19.4 billion, five-year GPU infrastructure contract with Microsoft Corporation (NASDAQ:MSFT).

Benzinga

Eric Trump's Director Plans Scrapped, Shifted To Observer Role On Alt5 Sigma Board After Nasdaq Review

Eric Trump, son of Donald Trump, will now serve as an observer on Alt5 Sigma's (NASDAQ:ALTS) board instead of taking a director seat.

Benzinga

Tesla Courts Bay Area Airports For Ride-Hailing Access: Report

Tesla, Inc. (NASDAQ:TSLA) shares held steady Tuesday as fresh emails and airport statements reportedly shed light on the automaker’s push to expand its ride-hailing footprint in California.

International Business Times UK

Real Estate Meets Crypto: Caliber Unveils Long-Term Chainlink Strategy — Staking, Yield and Growth

Caliber launches pioneering Chainlink reserve strategy in its corporate treasury, blending real estate assets with digital innovation.

Benzinga

Dow Surges Over 100 Points; Korn Ferry Earnings Top Views

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday.

1 … 131 132 133 134

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations